Linda Rhodes
CIK 1336284 · CHIEF SCIENTIFIC OFFICER · last filed 2024-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$962.5K
Companies
3
Total Filings
33
Lifetime Open-Market Net
-$1.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 4
33 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-08 | ZTS | Sell (S) | −1,087 | -$173.0K | EDGAR |
| 2020-08-04 | ZTS | Mixed | +2,550 | -$111.2K | EDGAR |
| 2020-02-13 | ZTS | Grant (A) | — | $0 | EDGAR |
| 2019-02-14 | ZTS | Grant (A) | — | $0 | EDGAR |
| 2018-02-15 | ZTS | Grant (A) | — | $0 | EDGAR |
| 2017-08-14 | ICCC | — | — | $0 | EDGAR |
| 2017-08-07 | ZTS | Grant (A) | — | $0 | EDGAR |
| 2016-04-15 | ICCC | Disp (D) | −1,009 | -$6.4K | EDGAR |
| 2016-02-01 | ICCC | Buy (P) | +2,857 | $15.0K | EDGAR |
| 2015-04-28 | ARATANA THERAPEUTICS, INC. (PETX) Delisted | Mixed | +2,200 | -$225.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.